| Subject: | FDA Publishes Notice of Recall of BioMerieux Simplastin HTF Tissue Reagent |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 23 May 2005 - 10:00 am |
| BioMerieux Inc. is issuing a new alert on a recall of Simplastin HTF, a tissue thromboplastin reagent used in laboratory diagnostic testing of patients receiving anticoagulant testing. The initial recall of MDA Simplastin HTF tissue reagents was initiated in March 2005, but the notification to purchasers incorrectly indicated that the mislabeling problem was of no clinical significance. The new alert is being issued because the mislabeling problems with certain lots of MDA Simplastin HTF could... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
